{
    "clinical_study": {
        "@rank": "134617", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Vit-E", 
                "arm_group_type": "Active Comparator", 
                "description": "600 IU on 12 hours before angiography and 400 IU on 2 hours before angiography"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of vitamin E on preventing from\n      incidence of contrast induced acute kidney injury  (CI-AKI) in the patients who undergone\n      coronary angiography."
        }, 
        "brief_title": "Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stable Angina", 
            "Unstable Angina", 
            "Non ST Segment Elevation Myocardial Infarction", 
            "Post MI"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Angina, Unstable", 
                "Infarction", 
                "Acute Kidney Injury", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. All patients whon have either stable coronary artery disease (CAD) or recent acute\n             coronary disease (ACS) and are scheduled for coronary angiography.\n\n          2. Patients who have eGFR \u226460 ml/min/1.73 m2\n\n        Exclusion Criteria:\n\n          1. Allergy to contrast media\n\n          2. Cardiogenic shock\n\n          3. Pulmonary edema\n\n          4. Overt cardiac failure or left ventricular ejection fraction \u2264 30%\n\n          5. Acute kidney injury\n\n          6. The history of receiving contrast media for any medical diagnostic or therapeutic\n             procedures during previous 5 days\n\n          7. The history of dialysis\n\n          8. Being pregnant\n\n          9. Having recent acute myocardial infarction\n\n         10. Taking antioxidants and nephrotoxic drugs including NSAID and ACE-I on previous 2\n             days"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "290", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070679", 
            "org_study_id": "UMSU-Cardiology-1"
        }, 
        "intervention": {
            "arm_group_label": "Vit-E", 
            "intervention_name": "Vitamin E", 
            "intervention_type": "Drug", 
            "other_name": "Alpha-tocopherol"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "keyword": [
            "Alpha-tocopherol", 
            "Vitamin E", 
            "Contrast-Induced Acute Kidney Injury", 
            "Coronary angiography"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": [
            {
                "contact": {
                    "email": "mmohammadzad@gmail.com", 
                    "last_name": "Mir Hossein Seyyed-Mohammadzad", 
                    "phone": "+989143458377"
                }, 
                "facility": {
                    "address": {
                        "city": "Urmia", 
                        "country": "Iran, Islamic Republic of", 
                        "state": "West-Azerbaijan"
                    }, 
                    "name": "Seyyed-al-Shohada Heart Center, UMSU"
                }, 
                "investigator": {
                    "last_name": "Yousef Rezaei, GP", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Urmia", 
                        "country": "Iran, Islamic Republic of", 
                        "state": "West-Azerbaijan"
                    }, 
                    "name": "Taleghani Hospital, UMSU"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "mmohammadzad@gmail.com", 
            "last_name": "Mir Hossein Seyyed-Mohammadzad, Interventionist", 
            "phone": "+989143458377"
        }, 
        "overall_contact_backup": {
            "email": "yousefrezaei1986@gmail.com", 
            "last_name": "Yousef Rezaei", 
            "phone": "+989126231864"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The development of CI-AKI in group receiving vitamin E compared with placebo", 
            "safety_issue": "Yes", 
            "time_frame": "Within 72 hours after coronary angiography"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070679"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Urmia University of Medical Sciences", 
            "investigator_full_name": "Chancellor of research", 
            "investigator_title": "Mir Hossein Seyyed-Mohammadzad", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Changes in the serum level of Cr and the amount of eGFR", 
            "safety_issue": "Yes", 
            "time_frame": "Within 72 hours"
        }, 
        "source": "Urmia University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Urmia University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}